Related Experiment Video
Updated: May 31, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Recurrent apnoea post immunisation: Informing re-immunisation policy
Vanessa Clifford1, Nigel W Crawford, Jenny Royle
1SAEFVIC, Murdoch Children's Research Institute, Melbourne, Australia. vanessa.clifford@rch.org.au
Insights
Preterm infants experiencing apnoea after immunisation have an 18% recurrence risk. Lower birth weight and prematurity complications are risk factors, but a third episode is unlikely. Monitoring is recommended.
Area of Science:
- Neonatalogy
- Pediatric Vaccinology
- Public Health Surveillance
Background:
- Routine immunizations are recommended based on chronological age, but concerns about adverse events following immunization (AEFI) in preterm infants often lead to delays.
- Apnoea with or without bradycardia temporally associated with immunisation (AEFI) can occur in a small number of infants, with unknown risk factors and recurrence rates.
- This uncertainty complicates immunization planning for vulnerable preterm infants.
Purpose of the Study:
- To determine the recurrence rates of immunisation-associated apnoea in preterm and term infants.
- To identify potential risk factors for recurrent apnoea in preterm infants following immunisation.
Main Methods:
- A retrospective analysis of apnoea +/- bradycardia AEFIs reported to SAEFVIC in Victoria, Australia, from May 2007 to April 2010.
- Included preterm and term infants; apnoea was defined as occurring up to 48 hours post-immunisation.
Main Results:
- 18% (7/38) of preterm infants with initial apnoea experienced recurrence with subsequent immunisations.
- Lower birth weight and ongoing hospitalisation for prematurity complications were identified as risk factors for recurrence (p=0.04 and p=0.01, respectively).
- No preterm infant experienced a third episode; no term infants showed recurrence.
Conclusions:
- A significant risk of recurrent apnoea exists in preterm infants following immunisation.
- Preterm infants with post-immunisation apnoea should undergo cardio-respiratory monitoring for at least 24 hours after subsequent vaccinations.
Background:
Preterm infants should receive immunisations according to their chronological, rather than gestational, age however concern about possible adverse events following immunisation (AEFI) in this group often means routine immunisations are delayed. A small number of infants may have apnoea with or without bradycardia temporally associated with immunisation. The risk factors for, and recurrence rate of apnoea with subsequent immunisations are unknown, which makes planning for subsequent immunisations for these highly vulnerable infants difficult.
Aim:
To determine recurrence rates for apnoea temporally associated with immunisation in preterm and term infants and to explore potential risk factors associated with recurrent apnoea in preterm infants.
Method:
A retrospective analysis of all apnoea +/-bradycardia AEFIs in preterm and term infants, reported to the Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Victoria, Australia over a 3-year period from May 2007 to April 2010. Apnoea +/-bradycardia was defined as temporally associated with immunisation if it occurred up to 48h after immunisation.
Results:
7 out of 38 [18%, 95% confidence interval 6-31%] preterm infants with apnoea +/-bradycardia post initial immunisation had recurrent apnoea with subsequent immunisations. Possible risk factors for recurrence included: lower birth weight (p=0.04) and ongoing hospitalisation for complications relating to prematurity (p=0.01). No preterm infant with recurrent apnoea had a third episode of apnoea with subsequent immunisation. None of the 8 term infants with a reported apnoea AEFI had recurrence of apnoea with subsequent immunisation.
Conclusion:
There is a risk of recurrence of apnoea associated with immunisation in preterm infants. We recommend that preterm infants with apnoea post immunisation should receive reliable cardio-respiratory monitoring for a minimum of 24h following the next scheduled immunisation.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Vaccinations
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

